Compound for treating neurodegenerative disorders
US12409161B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 11, 2020 |
| Grant date | Sep 9, 2025 |
| Priority date | — |
| Expiry date | Jan 7, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to use of a compound with a substituted bicyclic structure, a pharmaceutically acceptable salt, stereoisomer, solvate, polymorph, tautomer, isotopic compound, metabolite or prodrug thereof in the preparation of a medicament for preventing or treating polyglutamine (polyQ) related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.